Literature DB >> 16185662

Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells.

J J Xie1, L Y Xu, H H Zhang, W J Cai, R Q Mai, Y M Xie, Z M Yang, Y D Niu, Z Y Shen, E M Li.   

Abstract

Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility in various transformed cells. The overexpression of fascin in esophageal squamous cell carcinoma (ESCC) has been described only recently, but the roles and mechanism still remained unclear. Here, by using RNA interference (RNAi), we have stably silenced the expression of the fascin in EC109 cells, an ESCC cell line. Down-regulation of fascin resulted in a suppression of cell proliferation and as well as a decrease in cell invasiveness. Furthermore, we revealed that fascin might have functions in regulating tumor growth in vivo. The effect of fascin on cell invasiveness correlated with the activation of matrix metalloproteases such as MMP-2 and MMP-9. We examined that fascin down-expression also led to a decrease of c-erbB-2 and beta-catenin at the protein level. These results suggested that fascin might play crucial roles in regulating neoplasm progression of ESCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185662     DOI: 10.1016/j.bbrc.2005.09.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation.

Authors:  Xiao-Feng Lu; En-Min Li; Ze-Peng Du; Jian-Jun Xie; Zhang-Yan Guo; Shu-Ying Gao; Lian-Di Liao; Zhong-Ying Shen; Dong Xie; Li-Yan Xu
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

2.  Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma.

Authors:  Mikiko Takikita; Nan Hu; Jian-Zhong Shou; Carol Giffen; Quan-Hong Wang; Chaoyu Wang; Stephen M Hewitt; Philip R Taylor
Journal:  Anticancer Res       Date:  2011-03       Impact factor: 2.480

3.  Cytoplasmic HDPR1 is involved in regional lymph node metastasis and tumor development via beta-catenin accumulation in esophageal squamous cell carcinoma.

Authors:  Jian Hou; En-Min Li; Jin-Hui Shen; Zhi-Yong Wu; Xiu-E Xu; Jian-Yi Wu; Jian Shen; Ming-Zhou Guo; Li-Yan Xu
Journal:  J Histochem Cytochem       Date:  2011-04-27       Impact factor: 2.479

4.  Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.

Authors:  Wen-Chiuan Tsai; Lai-Fa Sheu; Shin Nieh; Cheng-Ping Yu; Gung-Huan Sun; Yeh-Feng Lin; Ann Chen; Jong-Shiaw Jin
Journal:  World J Urol       Date:  2006-09-23       Impact factor: 4.226

5.  Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma.

Authors:  Yan-Yi Jiang; De-Chen Lin; Anand Mayakonda; Masaharu Hazawa; Ling-Wen Ding; Wen-Wen Chien; Liang Xu; Ye Chen; Jin-Fen Xiao; William Senapedis; Erkan Baloglu; Deepika Kanojia; Li Shang; Xin Xu; Henry Yang; Jeffrey W Tyner; Ming-Rong Wang; H Phillip Koeffler
Journal:  Gut       Date:  2016-05-10       Impact factor: 23.059

6.  Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.

Authors:  Jian-Jun Xie; Li-Yan Xu; Jian-Yi Wu; Zhong-Ying Shen; Qing Zhao; Ze-Peng Du; Zhuo Lv; Wei Gu; Feng Pan; Xiu-E Xu; Dong Xie; En-Min Li
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

7.  The role of fascin in the migration and invasiveness of malignant glioma cells.

Authors:  Jeong Hyun Hwang; Christian A Smith; Bodour Salhia; James T Rutka
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

8.  Expression of fascin in thyroid neoplasms: a novel diagnostic marker.

Authors:  Guang Chen; Fa-Ren Zhang; Jiang Ren; Li-Hua Tao; Zhong-Ying Shen; Zhuo Lv; Shi-Jiang Yu; Bing-Fei Dong; Li-Yan Xu; En-Min Li
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-15       Impact factor: 4.553

9.  miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.

Authors:  T Chiyomaru; H Enokida; S Tatarano; K Kawahara; Y Uchida; K Nishiyama; L Fujimura; N Kikkawa; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

10.  High-grade glioma before and after treatment with radiation and Avastin: initial observations.

Authors:  Ingeborg Fischer; Clare H Cunliffe; Robert J Bollo; Shahzad Raza; David Monoky; Luis Chiriboga; Erik C Parker; John G Golfinos; Patrick J Kelly; Edmond A Knopp; Michael L Gruber; David Zagzag; Ashwatha Narayana
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.